Trials / Completed
CompletedNCT00817817
A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)
An Open-Label, Comparative, Randomized, Parallel, Multicenter Study to Determine the Efficacy and Safety of Two Dry Powder Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, comparative, randomized, parallel, multicenter study in asthmatics to determine whether the administration of dry powder inhaled mometasone furoate (MF) 400 μg in a monodose capsule device would be comparable to administration of powder inhaled MF 400 μg in a multidose device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MF | One evening dose of dry powder inhaled MF 400 μg (Multidose device). |
| DEVICE | MF | One evening dose of dry powder inhaled 400 μg (400 μg capsules - Monodose). |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2003-05-01
- Completion
- 2003-05-01
- First posted
- 2009-01-07
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00817817. Inclusion in this directory is not an endorsement.